The European Rare Kidney Disease Reference Network


Journal Watch

AD structural kidney disorders

Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
Author(s): Lam HC, Siroky BJ, Henske EP
Source: Nat Rev Nephrol 2018 Nov;14(11):704-716
Publication date: 2018-11
Tuberous sclerosis complex: new insights into clinical and therapeutic approach.
Author(s): Volpi A, Sala G, Lesma E, Labriola F, Righetti M, Alfano RM, Cozzolino M
Source: J Nephrol 2018 Nov 7;
Publication date: 2018-11-7
Mechanism of Fibrosis in HNF1B-Related Autosomal Dominant Tubulointerstitial Kidney Disease.
Author(s): Chan SC, Zhang Y, Shao A, Avdulov S, Herrera J, Aboudehen K, Pontoglio M, Igarashi P
Source: J Am Soc Nephrol 2018 Aug 10;
Publication date: 2018-08-10
Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2.
Author(s): Bissler JJ, Budde K, Sauter M, Franz DN, Zonnenberg BA, Frost MD, Belousova E, Berkowitz N, Ridolfi A, Christopher Kingswood J
Source: Nephrol Dial Transplant 2018 Jul 19;
Publication date: 2018-07-19
Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study.
Author(s): Janssens P, Van Hoeve K, De Waele L, De Rechter S, Claes KJ, Van de Perre E, Wissing KM, Bammens B, Jansen A, Mekahli D
Source: Pediatr Nephrol 2018 Jul 9;
Publication date: 2018-07-9
+ Show 1 more...